Panache Ventures — 2026 Investments
2 investments dated 2026 · listed companies and verified rows first · show all
biossil is an AI-native biopharma company developing late-stage drug programs for life-threatening conditions with unmet needs, including sickle cell disease, idiopathic pulmonary fibrosis, glioblastoma, breast cancer, and Alzheimer's disease.
AI & Machine LearningBiotechHealthtechToronto, CA
Alexander I. Mosa(MD PhD)Anthony Mouchantaf(JD MBA)
Co-investorsFounders Fund137 VenturesDRI HealthcareGolden VenturesQuiet CapitalStaircase Ventures
Soma operates an energy intelligence platform that connects power generation, battery storage, and large energy loads such as data centers into a real-time coordination layer to optimize and deliver power.
AI & Machine LearningCleantechEnergyRio de Janeiro, BR
Mario Souto(Founder)inAthanasios Caramanolis(Chief Executive Officer)in
Co-investorsCategory VenturesHaystackRRE VenturesTO VCUncork Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.